Document is current
Any future updates will be listed below
-
Authors
Puri, Sapna
Maachi, Hasna
Nair, Gopika
Russ, Holger A.
Chen, Richard
Pulimeno, Pamela
Cutts, Zachary
Ntranos, Vasilis http://orcid.org/0000-0002-2477-0670
Hebrok, Matthias http://orcid.org/0000-0002-3833-8862
-
Funding
Funding for this research was provided by:
JDRF (1-PNF-2016-320-S-B)
- License Information
-
More Information
Article History
Received: 1 June 2021
Accepted: 12 December 2023
First Online: 18 January 2024
Competing interests
: MH holds stocks in Encellin Inc. and Thymmune Therapeutics Inc. and has received research support from Eli Lilly. He consults for Boxer Capital and CV Next and holds stock in the latter. He is the co-founder of Minutia Inc. and holds stocks and options in the company. The remaining authors declare no competing interests.
